4.0
24 Apr 2025
Current employee, more than 8 years
Prague
Recommend
CEO approval
Business outlook
Pros
Decent pay, good team, nice offices
Cons
As key drug Keytruda approaches end of patent, company is in flux. Cost cutting and pressure increase.
Check out your Company Bowl for anonymous work chats.